Literature DB >> 28132418

Switching, Adverse Effects and Use of Over-the-Counter Analgesics among Users of Oral Anticoagulants: A Pharmacy-based Survey.

Maja Hellfritzsch1,2, Lea Maria Rønneberg Hyllested3, Line Meegaard4, Alexander Wiberg-Hansen3, Erik Lerkevang Grove5,6, Anton Pottegård1,3.   

Abstract

Oral anticoagulants are widely used but information on important aspects in that respect is not available from medical registers or clinical databases. Therefore, we conducted a survey including patients filling a prescription for oral anticoagulants at two large Danish community pharmacies. We collected information concerning the patients' knowledge of their anticoagulant treatment including prior drug switching. Further, patients were asked about use of over-the-counter analgesics, adverse effects and how the treatment affected their everyday life. Among 335 eligible patients, 301 (90%) agreed to participate. Atrial fibrillation was the most common indication (65%), and most patients filled a prescription for a non-vitamin K antagonist oral anticoagulant (NOAC) (58%). Among the 12% (n = 35) of participants who had switched oral anticoagulant treatment, 69% had switched from a vitamin K antagonist (VKA) to a NOAC. Switching was most frequently caused by inconvenience (34%) and adverse effects (23%). Although half of all patients had recently bought over-the-counter analgesics, purchase of ibuprofen and aspirin was rare (6%). More VKA users than NOAC users felt limited in their everyday life because of anticoagulant treatment (18% versus 9%). Among non-incident NOAC users, 21% had experienced adverse effects during their current treatment. Based on first-hand information from a large sample of anticoagulant users, we conclude that the main drug-related issues leading to anticoagulant switching and perceived limitations in everyday life were inconvenience and adverse effects. This varied between drug groups. Further, use of NSAIDs obtained over the counter was rare.
© 2017 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28132418     DOI: 10.1111/bcpt.12762

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  3 in total

1.  Using the Symmetry Analysis Design to Screen for Adverse Effects of Non-vitamin K Antagonist Oral Anticoagulants.

Authors:  Maja Hellfritzsch; Lotte Rasmussen; Jesper Hallas; Anton Pottegård
Journal:  Drug Saf       Date:  2018-07       Impact factor: 5.606

2.  Needle EMG induced muscle bleeding complication after guideline approved discontinuation of anticoagulation.

Authors:  Michael Bartl; Arne Krahn; Joachim Riggert; Walter Paulus
Journal:  Clin Neurophysiol Pract       Date:  2021-03-26

Review 3.  Strengths and weaknesses of 'real-world' studies involving non-vitamin K antagonist oral anticoagulants.

Authors:  A John Camm; Keith A A Fox
Journal:  Open Heart       Date:  2018-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.